Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Valuable Targets
6 min read
Progress of IL-17A Inhibitors in the Treatment of Autoimmune and Inflammatory Diseases
25 September 2023
IL-17A, or Interleukin-17A, is a cytokine that plays a crucial role in the human body's immune response.
Drug Insights
4 min read
ExploringCeftolozane's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
22 September 2023
This article summarized the latest R&D progress of Ceftolozane, the Mechanism of Action for Ceftolozane, and the drug target R&D trends for Ceftolozane.
Latest Hotspot
3 min read
MRM Health showcases encouraging findings from its Phase 2a Clinical Trial of MH002 for Ulcerative Colitis
22 September 2023
MRM Health NV has announced encouraging preliminary outcomes from its Phase 2a clinical study of MH002 against mild-to-moderate Ulcerative Colitis.
Drug Insights
4 min read
Decoding Tetracaine: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
22 September 2023
This article summarized the latest R&D progress of Tetracaine, the Mechanism of Action for Tetracaine, and the drug target R&D trends for Tetracaine.
Valuable Targets
5 min read
Analysis on the Clinical Research Progress of IL-23 inhibitors
22 September 2023
IL-23, or Interleukin-23, is a crucial cytokine that plays a significant role in the human body's immune response.
Drug Insights
5 min read
Deep Scientific Insights on Tesofensine's R&D Progress, Mechanism of Action, and Drug Target
22 September 2023
This article summarized the latest R&D progress of Tesofensine, the Mechanism of Action for Tesofensine, and the drug target R&D trends for Tesofensine.
Latest Hotspot
3 min read
Patient Receives First Dose of ALPK1 Inhibitor, DF-003, in Drug Farm's Phase 1 Clinical Trial
22 September 2023
Drug Farm, currently in the clinical phase, has shared the news of the first participant in the Phase 1 clinical experiment, testing DF-003, receiving their initial dosage.
Drug Insights
4 min read
An In-depth Analysis of Tenecteplase's R&D Progress and Mechanism of Action on Drug Target
22 September 2023
This article summarized the latest R&D progress of Tenecteplase, the Mechanism of Action for Tenecteplase, and the drug target R&D trends for Tenecteplase.
Valuable Targets
6 min read
Analysis on the Clinical Research Progress of MAO-B inhibitors
22 September 2023
Monoamine oxidase-B (MAO-B) is an enzyme found in the human body that plays a crucial role in the metabolism of neurotransmitters such as dopamine.
Drug Insights
4 min read
Sulfanilamide: Detailed Review of its Transformative R&D Success
22 September 2023
This article summarized the latest R&D progress of Sulfanilamide, the Mechanism of Action for Sulfanilamide, and the drug target R&D trends for Sulfanilamide.
Latest Hotspot
3 min read
The Abelacimab AF study was early terminated by the Data Monitoring Committee due to a major decline in bleeding compared to a DOAC
22 September 2023
The study on Atrial Fibrillation using Abelacimab was prematurely ended by the Data Monitoring Committee due to a massive decrease in bleeding compared to a DOAC.
Drug Insights
3 min read
Sulfadiazine Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs
22 September 2023
This article summarized the latest R&D progress of Sulfadiazine, the Mechanism of Action for Sulfadiazine, and the drug target R&D trends for Sulfadiazine.